T2 Biosystems, Inc. Deferred Tax Assets, Net of Valuation Allowance
T2 Biosystems, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $2.12 million as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2024-04-01
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.12M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.65M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $3.03M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $3.35M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2023-12-31 | $2.12M 10-K · filed 2024-04-01 |
| 2022-12-31 | $2.65M 10-K · filed 2024-04-01 |
| 2021-12-31 | $3.03M 10-K · filed 2023-03-31 |
| 2020-12-31 | $3.35M 10-K · filed 2022-03-23 |
| 2019-12-31 | $1.16M 10-K · filed 2021-03-31 |
| 2018-12-31 | $166.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $112.00K 10-K · filed 2019-03-14 |
| 2016-12-31 | $259.00K 10-K · filed 2018-03-19 |
| 2015-12-31 | $271.00K 10-K · filed 2017-03-15 |
| 2014-12-31 | $313.00K 10-K · filed 2016-03-09 |